Agency for International Development – Federal Register Recent Federal Regulation Documents

Results 201 - 250 of 536
Schedules of Controlled Substances: Removal of [123
Document Number: 2015-22919
Type: Rule
Date: 2015-09-11
Agency: Agency for Healthcare Research and Quality, Agency for International Development
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration removes [\123\I]ioflupane from the schedules of the Controlled Substances Act. This action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after an opportunity for a hearing through formal rulemaking. Prior to the effective date of this rule, [\123\I]ioflupane was, by definition, a schedule II controlled substance because it is derived from cocaine via ecgonine, both of which are schedule II controlled substances. This action removes the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle [\123\I]ioflupane.
Manufacturer of Controlled Substances Registration: PCAS-Nanosyn, LLC
Document Number: 2015-22626
Type: Notice
Date: 2015-09-09
Agency: Agency for Healthcare Research and Quality, Agency for International Development
PCAS-Nanosyn, LLC applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants PCAS-Nanosyn, LLC registration as a manufacturer of those controlled substances.
Importer of Controlled Substances Application: Akorn, Inc.
Document Number: 2015-22625
Type: Notice
Date: 2015-09-09
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Importer of Controlled Substances Application: Chattem Chemicals Inc.
Document Number: 2015-22624
Type: Notice
Date: 2015-09-09
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Abbas E. Sina, M.D.; Decision and Order
Document Number: 2015-21732
Type: Notice
Date: 2015-09-02
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Importer of Controlled Substances Application: Cambrex Charles City
Document Number: 2015-21557
Type: Notice
Date: 2015-08-31
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Importer of Controlled Substances Application: Noramco, Inc.
Document Number: 2015-21545
Type: Notice
Date: 2015-08-31
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Manufacturer of Controlled Substances Registration: Johnson Matthey Pharmaceutical Materials, Inc.
Document Number: 2015-21521
Type: Notice
Date: 2015-08-31
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Johnson Matthey Pharmaceutical Materials, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Johnson Matthey Pharmaceutical Materials, Inc. registration as a manufacturer of those controlled substances.
Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Document Number: 2015-21520
Type: Notice
Date: 2015-08-31
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Bulk Manufacturer of Controlled Substances Application: Rhodes Technologies
Document Number: 2015-21471
Type: Notice
Date: 2015-08-31
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Importer of Controlled Substances Application: Alltech Associates, Inc.
Document Number: 2015-21470
Type: Notice
Date: 2015-08-31
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Importer of Controlled Substances Application: Catalent CTS, LLC
Document Number: 2015-21464
Type: Notice
Date: 2015-08-31
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Arthur H. Bell, D.O.; Decision and Order
Document Number: 2015-20353
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
John R. Kregenow, D.D.S.; Decision and Order
Document Number: 2015-20352
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Victor B. Williams, M.D.; Decision and Order
Document Number: 2015-20351
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Nicholas Nardacci, M.D.; Decision and Order
Document Number: 2015-20350
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Ronald A. Green, M.D.; Decision and Order
Document Number: 2015-20349
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Devra Hamilton, N.P.; Decision and Order
Document Number: 2015-20348
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Jeffrey S. Holverson, M.D.; Decision and Order
Document Number: 2015-20346
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Bulk Manufacturer of Controlled Substances Application: IRIX Manufacturing, Inc.
Document Number: 2015-20285
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Bulk Manufacturer of Controlled Substances Application: Austin Pharma LLC
Document Number: 2015-20284
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Bulk Manufacturer of Controlled Substances Application: Alltech Associates, Inc.
Document Number: 2015-20283
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Importer of Controlled Substances Application: Cody Laboratories, Inc.
Document Number: 2015-20278
Type: Notice
Date: 2015-08-18
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV
Document Number: 2015-19655
Type: Proposed Rule
Date: 2015-08-11
Agency: Agency for Healthcare Research and Quality, Agency for International Development
The Drug Enforcement Administration proposes to place the substance eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6- dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2- yl)ethyl]amino]methyl]-2-methoxybenzoic acid), including its salts, isomers, and salts of isomers, into schedule IV of the Controlled Substances Act (CSA). This proposed scheduling action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule IV controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities, or possess), or propose to handle eluxadoline.
Manufacturer of Controlled Substances Registration: Patheon Pharmaceuticals, Inc.
Document Number: 2015-19173
Type: Notice
Date: 2015-08-05
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Patheon Pharmaceuticals, Inc. applied to be registered as a manufacturer of a certain basic class of controlled substance. The Drug Enforcement Administration (DEA) grants Patheon Pharmaceuticals, Inc. registration as a manufacturer of this controlled substance.
Manufacturer of Controlled Substances Registration: National Center for Natural Products Research (NIDA MPROJECT), Inc.
Document Number: 2015-19172
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
National Center for Natural Products Research (NIDA MPROJECT), Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants National Center for Natural Products Research (NIDA MPROJECT), Inc. registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Cody Laboratories, Inc.
Document Number: 2015-19168
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Cody Laboratories, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Cody Laboratories, Inc. registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Sigma Aldrich Research Biochemicals, Inc.
Document Number: 2015-19166
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Sigma Aldrich Research Biochemicals, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Sigma Aldrich Research Biochemicals, Inc. registration as a manufacturer of those controlled substances.
Bulk Manufacturer of Controlled Substances Application: Cedarburg Pharmaceuticals, Inc.
Document Number: 2015-19165
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Importer of Controlled Substances Registration: Meridian Medical Technologies
Document Number: 2015-19164
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Meridian Medical Technologies applied to be registered as an importer of a certain basic class of controlled substance. The Drug Enforcement Administration (DEA) grants Meridian Medical Technologies registration as an importer of this controlled substance.
Manufacturer of Controlled Substances Registration: Cayman Chemicals Company
Document Number: 2015-19163
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Cayman Chemicals Company applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Cayman Chemicals Company registration as a manufacturer of those controlled substances.
Importer of Controlled Substances Registration: Actavis Laboratories FL, Inc.
Document Number: 2015-19162
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Actavis Laboratories FL, Inc. applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Actavis Laboratories FL, Inc., registration as an importer of those controlled substances.
Importer of Controlled Substances Registration: Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC
Document Number: 2015-19159
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC registration as an importer of those controlled substances.
Importer of Controlled Substances Application: Research Triangle Institute
Document Number: 2015-19158
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Adeline Davies Essien, M.D.; Decision and Order
Document Number: 2015-19122
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Pedro E. Lopez, M.D.; Decision and Order
Document Number: 2015-19119
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
AIM Pharmacy & Surgical S. Corp. Order
Document Number: 2015-19116
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Manufacturer of Controlled Substances Registration: Cambrex Charles City
Document Number: 2015-19111
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Cambrex Charles City applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Cambrex Charles City registration as a manufacturer of those controlled substances.
Importer of Controlled Substances Registration: Almac Clinical Services Inc. (ACSI)
Document Number: 2015-19109
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Almac Clinical Services Inc. (ACSI) applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Almac Clinical Services Inc. (ACSI) registration as an importer of those controlled substances.
Importer of Controlled Substances Registration: Johnson Matthey, Inc.
Document Number: 2015-19107
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Johnson Matthey, Inc. applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Johnson Matthey, Inc., registration as an importer of those controlled substances.
Importer of Controlled Substances Registration: Hospira
Document Number: 2015-19106
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Hospira applied to be registered as an importer of certain basic class of controlled substances. The Drug Enforcement Administration (DEA) grants Hospira registration as an importer of this controlled substance.
Manufacturer of Controlled Substances Registration: Johnson Matthey, Inc.
Document Number: 2015-19100
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Johnson Matthey, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Johnson Matthey, Inc. registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Pharmacore, Inc.
Document Number: 2015-19099
Type: Notice
Date: 2015-08-04
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Pharmacore, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Pharmacore, Inc. registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Apertus Pharmaceuticals
Document Number: 2015-18695
Type: Notice
Date: 2015-07-30
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Apertus Pharmaceuticals applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Apertus Pharmaceuticals registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Cambridge Isotope Lab
Document Number: 2015-18693
Type: Notice
Date: 2015-07-30
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Cambridge Isotope Lab applied to be registered as a manufacturer of a certain basic class of controlled substance. The Drug Enforcement Administration (DEA) grants Cambridge Isotope Lab registration as a manufacturer of this controlled substance.
Manufacturer of Controlled Substances Registration: American Radiolabeled Chemicals, Inc.
Document Number: 2015-18692
Type: Notice
Date: 2015-07-30
Agency: Agency for Healthcare Research and Quality, Agency for International Development
American Radiolabeled Chemicals, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants American Radiolabeled Chemicals, Inc. registration as a manufacturer of those controlled substances.
Importer of Controlled Substances Registration: Stepan Company
Document Number: 2015-18691
Type: Notice
Date: 2015-07-30
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Stepan Company applied to be registered as an importer of certain basic class of controlled substances. The Drug Enforcement Administration (DEA) grants Stepan Company registration as an importer of this controlled substance.
Importer of Controlled Substances Registration: Pharmacore
Document Number: 2015-18690
Type: Notice
Date: 2015-07-30
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Pharmacore applied to be registered as an importer of a certain basic class of controlled substance. The Drug Enforcement Administration (DEA) grants Pharmacore registration as an importer of this controlled substance.
Syed Jawed Akhtar-Zaidi, M.D.; Decision and Order
Document Number: 2015-17719
Type: Notice
Date: 2015-07-20
Agency: Agency for Healthcare Research and Quality, Agency for International Development
Schedules of Controlled Substances: Temporary Placement of Acetyl Fentanyl Into Schedule I
Document Number: 2015-17563
Type: Rule
Date: 2015-07-17
Agency: Agency for Healthcare Research and Quality, Agency for International Development
The Administrator of the Drug Enforcement Administration is issuing this final order to temporarily schedule the synthetic opioid, N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide (acetyl fentanyl), and its optical, positional, and geometric isomers, salts and salts of isomers, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. This action is based on a finding by the Administrator that the placement of this opioid substance into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, import, export, engage in research, or possess), or propose to handle, acetyl fentanyl.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.